Contract Option Exercises — January 21, 2026

HII Mission Tech ($682M GSA to 2028), RTX/Raytheon ($224M FAA to 2029), General Atomics ($282M DHS UAS to 2026) provide revenue backlog with $1.3B+ options upside.

Oracle ($995M VA EHR to 2026), Leidos/QTC ($136M VA medical FY26), Accenture ($192M IRS + $67M DOE to 2027) signal $1.4B committed with minimal outlays for future revenue.

Ares ($108M NASA to 2027), Firefly ($39M CLPS to 2030), Analogic ($64M TSA CT to 2033) add $500M+ potential via options in 11+ year horizons.

General Atomics UAS ($282M), S&K Security ($102M IST to 2030), Tribalco radios ($46M) total $430M with $300M+ options for recurring maintenance.

17 contracts with $0 outlay (e.g., Oracle $995M, HII $682M) vs. $2.5B+ obligated signal funding delays; 12 long-term (>5yr) awards to 2028-2039 expose to budget shifts.

Firm fixed price dominant (25/46 contracts, ~$3.5B) risks margins on cost overruns in IT/space (e.g., Peraton $320M, Westat $77M NAEP).

Nonprofit/JV concentration (e.g., Caltech $1.69B NASA, WE2 $227M DOE) limits equity upside; small biz set-asides (15 contracts) cap large-cap access.

$2.5B+ unexercised options (e.g., HII $682M to $1.36B, Analogic $64M to $276M) across 30+ contracts offer 40% avg. upside if exercised.

NASA space R&D ($2.1B, 8 contracts to 2039) and DHS security ($800M+) signal multi-year backlogs amid program continuity.

Low outlays (~$1.5B aggregate, 20-30%) in $6.9B portfolio imply undervalued near-term cash conversion for primes.

7 contracts totaling $2.1B (30% portfolio) to 2039 underscore stable funding for JPL/missions despite nonprofit tilt.

12 awards ($1.8B) in NAICS 541512/541519 for VA/IRS/DOE emphasize EHR/cyber needs to 2027.

9 contracts ($900M+) for UAS, radar, transport to 2030 reflect priority ops funding.

{"entity"=>"Huntington Ingalls (HII Mission Tech)", "reason"=>"$682M GSA award (largest non-NASA) with $1.36B potential and $0 outlay signals backlog explosion.", "trigger"=>"Option exercise >$200M or outlays >10% by Q2 2026"}

{"entity"=>"RTX Corp (Raytheon)", "reason"=>"$224M FAA to 2029 + NASA SAFER adds visibility; firm fixed price margin test.", "trigger"=>"Accelerated outlays or new space wins"}

{"entity"=>"Oracle Health", "reason"=>"$995M VA EHR (2nd largest) at $0 outlay positions for health IT dominance.", "trigger"=>"FY26 funding release confirming $126M options"}

{"entity"=>"Caltech/NASA JPL pipeline", "reason"=>"$1.69B total neutral but proxies space spending trends for industry.", "trigger"=>"Modifications signaling Phase B transition"}